Exosomes derived from synovial mesenchymal stem cells (MSCs) of patients with RA, which exhibit high—level expression of miR—146a, can specifically target and IL—17—mediated pro—inflammatory signals and TLR pathways, thereby reducing the invasiveness of synovial fibroblasts [454]. Here, IL17A is linked to rheumatoid arthritis.